Top compounds associated with response to TMED3


Feature Type Standardized
Nominal ANOVA
mRNA SN-38 CTRPv2 pan-cancer AAC -0.21 1e-08
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.18 4e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.16 7e-08
mRNA GSK461364 CTRPv2 pan-cancer AAC -0.17 9e-08
mRNA alisertib CTRPv2 pan-cancer AAC -0.17 9e-08
mRNA etoposide CTRPv2 pan-cancer AAC -0.16 1e-07
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.19 2e-07
mRNA LY-2183240 CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 5e-07
mRNA Topotecan CTRPv2 pan-cancer AAC -0.16 1e-06
Download CSV